Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Htg Molecular Diagnostics Stock Quote

Htg Molecular Diagnostics (NASDAQ: HTGM)

$0.00
(0.0%)
$0.00
Price as of April 15, 2024, 12:33 p.m. ET

Htg Molecular Diagnostics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
HTGM -99.95% -100.00% -92.02% -100%
S&P +23.57% +76.22% +11.98% +142%

Htg Molecular Diagnostics Company Info

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.